News tagged with gastrointestinal cancers
The Medical Minute: What is myelodysplastic syndrome?
Television journalist and host of "Good Morning America" Robin Roberts announced this week that she has myelodysplastic syndrome, or MDS, an uncommon blood and bone marrow disorder.
Cancer
Jun 15, 2012 |
not rated yet |
1
PET imaging could lead to better care for neuroendocrine cancer
A method of molecular imaging that pinpoints hormonally active tissues in the body could change the course of treatment for a remarkable number of neuroendocrine cancer patients, say researchers at the Society of Nuclear ...
Cancer
Jun 11, 2012 |
not rated yet |
0
Clinical trial design supports original accelerated approval of sunitinib for GIST
Patients benefitted from an important design element in the pivotal phase III clinical trial that led to Food and Drug Administration and worldwide regulatory approval of sunitinib for the treatment of gastrointestinal stromal ...
Cancer
Jun 01, 2012 |
not rated yet |
0
Pancreatic cancer may be detected with simple intestinal probe
By simply shining a tiny light within the small intestine, close to that organ's junction with the pancreas, physicians at Mayo Clinic's campus in Florida have been able to detect pancreatic cancer 100 percent of the time ...
Cancer
May 21, 2012 |
not rated yet |
0
The cell's 'personal space:' A controlling factor in maintaining healthy tissue
Cells in normal tissue seem to have "personal space" issues. They know how much space they like, and if things get too tight, some cells are forced to leave.
Cancer
Apr 19, 2012 |
not rated yet |
0
|
UNC scientists describe protein that protects against colon cancer
A family of proteins is yielding new information about how it contributes to the development of gastrointestinal disease and cancer. A team of UNC scientists reports that in pre-clinical models, the absence of a protein called ...
Immunology
Apr 18, 2012 |
not rated yet |
0
|
Intensity Modulated Radiation Therapy optimal for localized prostate cancer
A treatment for localized prostate cancer known as Intensity Modulated Radiation Therapy (IMRT) is better than conventional conformal radiation therapy (CRT) for reducing certain side effects and preventing cancer recurrence, ...
Cancer
Apr 17, 2012 |
not rated yet |
0
Longer treatment with cancer drug following removal of GI tumor results in improved survival
Among patients with a high risk of recurrence of a gastrointestinal stromal tumor following surgery for its removal, patients who received imatinib (a drug to treat certain cancers) for 3 years instead of 1 had improved recurrence-free ...
Cancer
Mar 27, 2012 |
not rated yet |
0
Few young women with cancer take steps to preserve fertility during treatments
A new study has found that very few young women with cancer take steps to preserve their fertility while undergoing cancer therapy. Also, certain groups of young women are more likely to do so than others. Published early ...
Cancer
Mar 26, 2012 |
not rated yet |
0
Pressures to increase volume of colonoscopies adversely impacts how screenings are performed
Researchers at Mount Sinai School of Medicine have found that 92 percent of more than 1,000 gastroenterologists responding to a survey believed that pressures to increase the volume of colonoscopies adversely impacted how ...
Cancer
Mar 12, 2012 |
not rated yet |
0
Novartis says EU approves expanded use of Glivec
Swiss pharmaceutical group Novartis said Monday the European Union will allow it to expand its use of the drug Glivec to treat certain rare forms of gastrointestinal cancer.
Medications
Feb 27, 2012 |
not rated yet |
0
NGOs protest Novartis' Glivec patent quest in India
Several NGOs protested Thursday at the annual meeting of Novartis against the attempt by the Swiss pharmaceutical group's India company to obtain a patent for its anti-cancer drug Glivec.
Medications
Feb 23, 2012 |
not rated yet |
0
Three 'targeted' cancer drugs raise risk of fatal side effects
Treatment with three relatively new "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis led by scientists at Dana-Farber Cancer Institute. They added that ...
Cancer
Feb 06, 2012 |
5 / 5 (1) |
0
|
Drug improves survival of colorectal cancer patients, trial results show
An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer, an international phase III clinical trial found. The findings were presented ...
Cancer
Jan 18, 2012 |
not rated yet |
0
Personalized treatment for Crohn's Disease a step closer following gene mapping
Three new locations for Crohn's Disease genes have been uncovered by scientists at UCL using a novel gene mapping approach.
Genetics
Dec 08, 2011 |
not rated yet |
0
|
